3M | 8-K: Poll Results of 3M Meeting
3M | 8-K: 3M Reported First-Quarter Results
3M | 8-K: 3M Company Unaudited Pro Forma Condensed Consolidated Financial Statements
3M | 8-K: 3M Completes Spin-off of Solventum
3M | DEFA14A: Others
3M | DEFA14A: Others
3M | DEF 14A: Definitive information statements
3M | 8-K: 3M Announces New Leadership Appointments
3M | 8-K: 3M Board of Directors Approves Spin-off of Solventum
3M | 8-K: 3M Issuance of Senior Notes and Entering into Covenants and Agreements
3M | 8-K: Combat Arms Earplugs Settlement Set to Exceed 98% Participation Milestone
3M | 8-K: 3M Delivers Strong Fourth-Quarter Results and Improves Operational Performance and Exceeds Earnings and Cash Flow Expectations
3M | 8-K: Combat Arms Earplug Settlement Achieves Another Milestone with Participation of All Wave Plaintiffs
3M | 8-K/A: 3M Announces Claims Settlement Agreement (Amendment)
3M | 8-K: Chris Kemp and Adam London Offering to Acquire All of the Outstanding Common Stock of the Company Not Currently Owned by Mr. Kemp and Dr. London for an Indicative Purchase Price of $1.50 per Share in Cash
3M | 8-K: Tom Sweet Elected to 3M Board of Directors
3M | 8-K: 3M Reports Third Quarter 2023 Results and Increases Full Year Adjusted Earnings and Cash Flow Expectations
3M | 8-K: 3M Belgium Recently Self-Reported Data Related to Its Pfas Manufacturing Processes at the Zwijndrecht Facility to Relevant Flemish Regulatory Authorities Pursuant to the Emissions Safety Measure
3M | 8-K: Amendment No. 2 to Thecredit Agreement
3M | 8-K: 3M Announces Combat Arms Settlement
No Data